Patents by Inventor LAURA SAUNDERS

LAURA SAUNDERS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-DLL3 antibody drug conjugates
    Patent number: 9770518
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: September 26, 2017
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20170266313
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER
    Publication number: 20170266315
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20170266314
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • ANTI-DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20170266312
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: May 30, 2017
    Publication date: September 21, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: ROBERT A. STULL, LAURA SAUNDERS, SCOTT J. DYLLA, ORIT FOORD, DAVID LIU, MICHAEL TORGOV, HUI SHAO
  • Methods of making DLL3 antibody drug conjugates
    Patent number: 9764042
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: May 30, 2017
    Date of Patent: September 19, 2017
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti SEZ6 antibodies and methods of use
    Patent number: 9676850
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: June 13, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Laura Saunders, Scott J. Dylla, Orit Foord, Robert A. Stull, Michael Torgov, Hui Shao, David Liu
  • ANTI-DLL3 ANTIBODIES AND DRUG CONJUGATES FOR USE IN MELANOMA
    Publication number: 20170137533
    Abstract: Anti-DLL3 antibodies and antibody drug conjugates for use in the diagnosis and treatment of melanoma.
    Type: Application
    Filed: February 23, 2015
    Publication date: May 18, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Samuel WILLIAMS, Laura SAUNDERS, Kathryn A LOVING
  • NOVEL ANTI-DPEP3 ANTIBODIES AND METHODS OF USE
    Publication number: 20170044271
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 16, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: LAURA SAUNDERS, DEEPTI ROKKAM, DAVID LIU, MANDY BOONTANRART
  • NOVEL ANTI-DPEP3 ANTIBODIES AND METHODS OF USE
    Publication number: 20170029530
    Abstract: Provided herein are novel anti-DPEP3 antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: June 13, 2016
    Publication date: February 2, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Laura SAUNDERS, Deepti ROKKAM, David LIU, Mandy BOONTANRART
  • DLL3 MODULATORS AND METHODS OF USE
    Publication number: 20170000901
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: September 15, 2016
    Publication date: January 5, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9486537
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: November 8, 2016
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9480757
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: November 1, 2016
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • Anti-DLL3 antibody drug conjugates
    Patent number: 9481727
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: November 1, 2016
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao
  • NOVEL SEZ6 MODULATORS AND METHODS OF USE
    Publication number: 20160287720
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: August 27, 2014
    Publication date: October 6, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: David LIU, Deepti ROKKAM, Sheila BHEDDAH, Javier LOPEZ-MOLINA, Laura SAUNDERS
  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20160289332
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: November 5, 2014
    Publication date: October 6, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Marianne SANTAGUIDA, Monette AUJAY, Laura SAUNDERS, David LIU, Orit FOORD, Robert A. STULL, Paul Anthony ESCARPE
  • Anti-DLL3 antibody drug conjugates
    Publication number: 20160251431
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: September 1, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • Anti-DLL3 antibody drug conjugates
    Publication number: 20160250348
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: September 1, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • Anti-DLL3 antibody drug conjugates
    Publication number: 20160228571
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: April 21, 2016
    Publication date: August 11, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. STULL, Laura SAUNDERS, Scott J. DYLLA, Orit FOORD, David LIU, Michael TORGOV, Hui SHAO
  • KITS CONTAINING DLL3 ANTIBODY DRUG CONJUGATES
    Publication number: 20160158379
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: January 25, 2016
    Publication date: June 9, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu, Michael Torgov, Hui Shao